Global North America Patient Derived Xenograft (PDX) Models Market Size, Share, Growth Analysis Report - Forecast 2034
North America Patient Derived Xenograft (PDX) Models Market By Type (Mice Models, Rat Models), By Tumor Type (Gastrointestinal Tumor Models, Lung Tumor Models, Haematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Others), By Application (Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research, Biomarker Analysis, Oncology Research), By Technique (Heterotopic Implantation, Orthotropic Implantation), By End User (Academic and Research Organizations, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 210 Report Code: ZMR-7425
Published Date: Aug-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 75 Million | USD 281 Million | 18.0% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global North America Patient Derived Xenograft (PDX) Models Market Market, (2023 - 2030) (USD Million)
- 2.2 Global North America Patient Derived Xenograft (PDX) Models Market Market : snapshot
- Chapter 3. Global North America Patient Derived Xenograft (PDX) Models Market Market - Industry Analysis
- 3.1 North America Patient Derived Xenograft (PDX) Models Market Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The increasing demand for personalized medicine drives the market growth
- 3.3 Market Restraints
- 3.3.1. High cost and time-intensive processes might be hampering the market expansion
- 3.4 Market Opportunities
- 3.4.1. The increasing partnership offers a lucrative opportunity for the market growth
- 3.5 Market Challenges
- 3.5.1. The development of alternative techniques acts as a major challenge to the market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Tumor Type
- 3.7.2 Market attractiveness analysis By Model Type
- 3.7.3 Market attractiveness analysis By End User
- Chapter 4. Global North America Patient Derived Xenograft (PDX) Models Market Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global North America Patient Derived Xenograft (PDX) Models Market Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global North America Patient Derived Xenograft (PDX) Models Market Market - Tumor Type Analysis
- 5.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By Tumor Type
- 5.1.1 Global North America Patient Derived Xenograft (PDX) Models Market Market share, By Tumor Type, 2022 and 2030
- 5.2 Lung Cancer
- 5.2.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Lung Cancer, 2023 - 2030 (USD Million)
- 5.3 Pancreatic Cancer
- 5.3.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Pancreatic Cancer, 2023 - 2030 (USD Million)
- 5.4 Prostate Cancer
- 5.4.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Prostate Cancer, 2023 - 2030 (USD Million)
- 5.5 Breast Cancer
- 5.5.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Breast Cancer, 2023 - 2030 (USD Million)
- 5.6 Others
- 5.6.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Others, 2023 - 2030 (USD Million)
- 5.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By Tumor Type
- Chapter 6. Global North America Patient Derived Xenograft (PDX) Models Market Market - Model Type Analysis
- 6.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By Model Type
- 6.1.1 Global North America Patient Derived Xenograft (PDX) Models Market Market share, By Model Type, 2022 and 2030
- 6.2 Mice
- 6.2.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Mice, 2023 - 2030 (USD Million)
- 6.3 Rats
- 6.3.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Rats, 2023 - 2030 (USD Million)
- 6.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By Model Type
- Chapter 7. Global North America Patient Derived Xenograft (PDX) Models Market Market - End User Analysis
- 7.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By End User
- 7.1.1 Global North America Patient Derived Xenograft (PDX) Models Market Market share, By End User, 2022 and 2030
- 7.2 Pharmaceutical and Biopharmaceutical Companies
- 7.2.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Pharmaceutical and Biopharmaceutical Companies, 2023 - 2030 (USD Million)
- 7.3 Academic & Research Institutes
- 7.3.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by Academic & Research Institutes, 2023 - 2030 (USD Million)
- 7.4 CROs & CDMOs
- 7.4.1 Global North America Patient Derived Xenograft (PDX) Models Market Market by CROs & CDMOs, 2023 - 2030 (USD Million)
- 7.1 Global North America Patient Derived Xenograft (PDX) Models Market Market overview: By End User
- Chapter 8. North America Patient Derived Xenograft (PDX) Models Market Market - Regional Analysis
- 8.1 Global North America Patient Derived Xenograft (PDX) Models Market Market Regional Overview
- 8.2 Global North America Patient Derived Xenograft (PDX) Models Market Market Share, by Region, 2022 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, 2023 - 2030 (USD Million)
- 8.3.1.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, by Country, 2023 - 2030 (USD Million)
- 8.3.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, 2023 - 2030 (USD Million)
- 8.4 North America North America Patient Derived Xenograft (PDX) Models Market Market, by Tumor Type, 2023 - 2030
- 8.4.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, by Tumor Type, 2023 - 2030 (USD Million)
- 8.5 North America North America Patient Derived Xenograft (PDX) Models Market Market, by Model Type, 2023 - 2030
- 8.5.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, by Model Type, 2023 - 2030 (USD Million)
- 8.6 North America North America Patient Derived Xenograft (PDX) Models Market Market, by End User, 2023 - 2030
- 8.6.1 North America North America Patient Derived Xenograft (PDX) Models Market Market, by End User, 2023 - 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Champions Oncology Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 THE JACKSON LABORATORY
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Bioduro
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Charles River Laboratories
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Oncodesign
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Biocytogen
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Crown Bioscience Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Creative Animodel
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Covance Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Explora BioLabs and Hera BioLabs among others.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.1 Champions Oncology Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global North America Patient Derived Xenograft (PDX) Models Market Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global North America Patient Derived Xenograft (PDX) Models Market Market attractiveness, By Tumor Type
- 6. Global North America Patient Derived Xenograft (PDX) Models Market Market attractiveness, By Model Type
- 7. Global North America Patient Derived Xenograft (PDX) Models Market Market attractiveness, By End User
- 8. Global North America Patient Derived Xenograft (PDX) Models Market Market share by Tumor Type, 2023 and 2030 (USD Million)
- 9. Global North America Patient Derived Xenograft (PDX) Models Market Market by Lung Cancer, 2023 - 2030 (USD Million)
- 10. Global North America Patient Derived Xenograft (PDX) Models Market Market by Pancreatic Cancer, 2023 - 2030 (USD Million)
- 11. Global North America Patient Derived Xenograft (PDX) Models Market Market by Prostate Cancer, 2023 - 2030 (USD Million)
- 12. Global North America Patient Derived Xenograft (PDX) Models Market Market by Breast Cancer, 2023 - 2030 (USD Million)
- 13. Global North America Patient Derived Xenograft (PDX) Models Market Market by Others, 2023 - 2030 (USD Million)
- 14. Global North America Patient Derived Xenograft (PDX) Models Market Market share by Model Type, 2023 and 2030 (USD Million)
- 15. Global North America Patient Derived Xenograft (PDX) Models Market Market by Mice, 2023 - 2030 (USD Million)
- 16. Global North America Patient Derived Xenograft (PDX) Models Market Market by Rats, 2023 - 2030 (USD Million)
- 17. Global North America Patient Derived Xenograft (PDX) Models Market Market share by End User, 2023 and 2030 (USD Million)
- 18. Global North America Patient Derived Xenograft (PDX) Models Market Market by Pharmaceutical and Biopharmaceutical Companies, 2023 - 2030 (USD Million)
- 19. Global North America Patient Derived Xenograft (PDX) Models Market Market by Academic & Research Institutes, 2023 - 2030 (USD Million)
- 20. Global North America Patient Derived Xenograft (PDX) Models Market Market by CROs & CDMOs, 2023 - 2030 (USD Million)
- 21. Global North America Patient Derived Xenograft (PDX) Models Market Market share, by Region, 2023 and 2030
- 22. North America North America Patient Derived Xenograft (PDX) Models Market Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global North America Patient Derived Xenograft (PDX) Models Market Market: Snapshot
- 2. Drivers of the North America Patient Derived Xenograft (PDX) Models Market Market: impact analysis
- 3. North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Tumor Type, 2023 - 2030 (USD Million)
- 4. North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Model Type, 2023 - 2030 (USD Million)
- 5. North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By End User, 2023 - 2030 (USD Million)
- 6. The U.S. North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Tumor Type, 2023 - 2030 (USD Million)
- 7. The U.S. North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Model Type, 2023 - 2030 (USD Million)
- 8. The U.S. North America Patient Derived Xenograft (PDX) Models Market Market revenue, By End User, 2023 - 2030 (USD Million)
- 9. Canada North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Tumor Type, 2023 - 2030 (USD Million)
- 10. Canada North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Model Type, 2023 - 2030 (USD Million)
- 11. Canada North America Patient Derived Xenograft (PDX) Models Market Market revenue, By End User, 2023 - 2030 (USD Million)
- 12. Mexico North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Tumor Type, 2023 - 2030 (USD Million)
- 13. Mexico North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Model Type, 2023 - 2030 (USD Million)
- 14. Mexico North America Patient Derived Xenograft (PDX) Models Market Market revenue, By End User, 2023 - 2030 (USD Million)
- 15. Rest of North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Tumor Type, 2023 - 2030 (USD Million)
- 16. Rest of North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By Model Type, 2023 - 2030 (USD Million)
- 17. Rest of North America North America Patient Derived Xenograft (PDX) Models Market Market revenue, By End User, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
Tumor tissue or patient cells are injected into humanized or immune-deficient mice to create patient-derived xenografts (PDX), which are cancer models. The best study model for assessing effectiveness is the PDX model, which replicates the biology of human tumors and allows the disease to grow naturally. In patient-derived xenograft (PDX) animal models, fresh human tumor tissues are surgically removed from patients or other patients and then promptly transplanted into immunodeficient mice.
The global north america patient derived xenograft (PDX) models market is expected to grow due to rising cancer research, demand for personalized medicine, and the need for more accurate preclinical drug testing models.
According to a study, the global north america patient derived xenograft (PDX) models market size was worth around USD 104.71 Million in 2024 and is expected to reach USD 555.53 Million by 2034.
The global north america patient derived xenograft (PDX) models market is expected to grow at a CAGR of 18.16% during the forecast period.
North America is expected to dominate the north america patient derived xenograft (PDX) models market over the forecast period.
Leading players in the global north america patient derived xenograft (PDX) models market include Crown Bioscience Inc. (U.S.), THE JACKSON LABORATORY (U.S.), Champions Oncology, Inc. (U.S.), Charles River Laboratories (U.S.), Wuxi AppTec (China), Oncodesign (Canada), Aragen Bioscience (India), Biocytogen (U.S.), Bioduro (U.S.), Creative Animodel (U.S.), Covance Inc. (U.S.), EPO Berlin-Buch GmbH (Germany), EUROPDX. (Belgium), Explora BioLabs (U.S.), Hera BioLabs (U.S.), Horizon discovery Ltd. (U.K.), Pharmatest Services (Finland), Urospehere SAS (Cyprus), Xentech (France), Xenopat (France), among others.
The report explores crucial aspects of the north america patient derived xenograft (PDX) models market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed